oa CADUCEUS, SCIPIO, ALCADIA: Cell therapy trials using cardiac-derived cells for patients with post myocardial infarction LV dysfunction, still evolving

References

1. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman D, Czer LS, Marbán L, Mendizabal A, Johnston PV, Russell SD, Schuleri KH, Lardo AC, Gerstenblith G, Marbán E. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet. 2012 379:9819:895–904. Available at: http://dx.doi.org/10.1016/S0140-6736(12)60195-0
   [Google Scholar]
2. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science. 2009 324:5923:98–102. Available at: http://dx.doi.org/10.1126/science.1164680
   [Google Scholar]
3. Senyo SE, Steinhauser ML, Pizzimenti CL, Yang VK, Cai L, Wang M, Wu T-D, Guerquin-Kern J-L, Lechene CP, Lee RT. Mammalian heart renewal by pre-existing cardiomyocytes. Nature. 2012 493:7432:433–436. Available at: http://dx.doi.org/10.1038/nature11682
   [Google Scholar]
4. Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D, Mammen PP, Rothermel BA, Olson EN, Sadek HA. Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci. 2013 110:1:187–192. Available at: http://dx.doi.org/10.1073/pnas.1208863110
   [Google Scholar]
5. Woo YJ, Panlilio CM, Cheng RK, Liao GP, Atluri P, Hsu VM, Cohen JE, Chaudhry HW. Therapeutic delivery of cyclin A2 induces myocardial regeneration and enhances cardiac function in ischemic heart failure. Circulation. 114::I-206–I-213. Available at: http://dx.doi.org/10.1161/CIRCULATIONAHA.105.000455
   [Google Scholar]
6. Eulalio A, Mano M, Ferro MD, Zentilin L, Sinagra G, Zacchigna S, Giacca M. Functional screening identifies miRNAs inducing cardiac regeneration. Nature. 2012 492:7429:376–381. Available at: http://dx.doi.org/10.1038/nature11739
   [Google Scholar]
7. Bolli R, Chugh AR, Damario D, Loughran JH, Stoddard MF, Ikram S, Beache GM, Wagner SG, Leri A, Hosoda T, Sanada F, Elmore JB, Goichberg P, Cappetta D, Solankhi NK, Fahsah I, Rokosh DG, Slaughter MS, Kajstura J, Anversa P. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet. 2011 378:9806:1847–1857. Available at: http://dx.doi.org/10.1016/s0140-6736(11)61590-0
   [Google Scholar]
8. Heusch G. SCIPIO brings new momentum to cardiac cell therapy. Lancet. 2011 378:9806:1827–1828. Available at: http://dx.doi.org/10.1016/S0140-6736(11)61648-6
   [Google Scholar]
9. Takehara N, Nagata M, Ogata T, Nakamura T, Matoba S, Gojo S, Sawada T, Yaku H, Matsubara H. The ALCADIA (Autologous Human Cardiac-derived Stem Cell To Treat Ischemic Cardiomyopathy) trial. AHA 2012; LBCT-20032
   [Google Scholar]
10. Takehara N, Tsutsumi Y, Tateishi K, Ogata T, Tanaka H, Ueyama T, Takahashi T, Takamatsu T, Fukushima M, Komeda M, Yamagishi M, Yaku H, Tabata Y, Matsubara H, Oh H. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. J Am Coll Cardiol. 2008 52:23:1858–1865. Available at: http://dx.doi.org/10.1016/j.jacc.2008.06.052
    [Google Scholar]
11. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med. 2013 5:2:191–209. Available at: http://dx.doi.org/10.1002/emmm.201201737
    [Google Scholar]